Impact of CKD and Hemodialysis on Treatment of Severely Calcified Lesions: The ECLIPSE Trial
Circulation: Cardiovascular Interventions · 2026-11-02
DOI: 10.1161/circinterventions.126.017556 ↗Abstract
Background: Chronic kidney disease (CKD) and coronary calcification increase risk for adverse events following drug-eluting stent (DES) implantation. We evaluated whether outcomes following vessel preparation with orbital atherectomy (OA) versus balloon angioplasty (BA) vary according to CKD. Methods: This pre-specified CKD sub-analysis of the prospective, multicenter ECLIPSE trial evaluated 2,001 patients with severely calcified lesions randomized to OA versus BA prior to DES. Independent predictors of two-year target-vessel failure (TVF)—a composite of cardiac death, target-vessel myocardial infarction (TV-MI), or ischemia-driven target-vessel revascularization (ID-TVR)—were determined using multivariable Cox proportional hazards modeling. Results: CKD (eGFR
EUVIMED